740
Views
135
CrossRef citations to date
0
Altmetric
Research Article

From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions

, &
Pages 187-224 | Published online: 09 Oct 2008

REFERENCES

  • Aitman T. J., Dong R., Vyse T. J., Norsworthy P. J., Johnson M. D., Smith J., Mangion J., Roberton-Lowe C., Marshall A. J., Petretto E., Hodges M. D., Bhangal G., Patel S. G., Sheehan-Rooney K., Duda M., Cook P. R., Evans D. J., Domin J., Flint J., Boyle J. J., Pusey C. D., Cook H. T. Copy number polymorphism in FCGR3 gene predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851–855
  • Akhtar A., Gasser S. M. The nuclear envelope and transcriptional control. Nat. Rev. Genet. 2007; 8: 507–517
  • Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M. C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S. The common PPARG Pro12Ala polymorphism is associated with decreased risk of Type-2 diabetes. Nat. Genet. 2000; 26: 76–80
  • Alving A. S., Carson P. E., Flanagan C. L., Ickes C. E. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124: 484–485
  • Anthoni H., Zucchelli M., Matsson H., Muller-Myhsok B., Fransson I., Schumacher J., Massinen S., Onkamo P., Warnke A., Griesemann H., Hoffmann P., Nopola-Hemmi J., Lyytinen H., Schulte-Korne G., Kere J., Nothen M. M., Peyrard-Janvid M. A locus on 2p12 containing the co-regulated MRPL19 and C2ORF3 genes is associated with dyslexia. Hum. Mol. Genet. 2007; 16: 667–677
  • Anway M. D., Cupp A. S., Uzumcu M., Skinner M. K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466–1469
  • Armaly M. F., Becker B. Intraocular pressure response to topical corticosteroids. Fed. Proc. 1965; 24: 1274–1278
  • Badano J. L., Katsanis N. Beyond Mendel: An evolving view of human genetic disease transmission. Nat. Rev. Genet. 2002; 3: 779–789
  • Bamber D.E., Fryer A. A., Strange R. C., Elder J. B., Deakin M., Rajagopal R., Fawole A., Gilissen R. A., Campbell F. C., Coughtrie M. W. Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 2001; 11: 679–685
  • Beales P.L., Badano J. L., Ross A. J., Ansley S. J., Hoskins B. E., Kirsten B., Mein C. A., Froguel P., Scambler P. J., Lewis R. A., Lupski J. R., Katsanis N. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in Non-Mendelian Bardet-Biedl syndrome. Am. J. Hum. Genet. 2003; 72: 1187–1199
  • Begovich A.B., Carlton V. E., Honigberg L. A., Schrodi S. J., Chokkalingam A. P., Alexander H. C., Ardlie K. G., Huang Q., Smith A. M., Spoerke J. M., Conn M. T., Chang M., Chang S. Y., Saiki R. K., Catanese J. J., Leong D. U., Garcia V. E., McAllister L. B., Jeffery D. A., Lee A. T., Batliwalla F., Remmers E., Criswell L. A., Seldin M. F., Kastner D. L., Amos C. I., Sninsky J. J., Gregersen P. K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004; 75: 330–337
  • Bellini G., Bravaccio C., Calamoneri F., Donatella C. M., Fiorillo P., Gagliano A., Mazzone D., del Giudice E. M., Scuccimarra G., Militerni R., Pascotto A. No evidence for association between dyslexia and DYX1C1 functional variants in a group of children and adolescents From Southern Italy. J. Mol. Neurosci. 2005; 27: 311–314
  • Berrozpe G., Agosti V., Tucker C., Blanpain C., Manova K., Besmer P. A distant upstream locus control region is critical for expression of the Kit Receptor Gene in mast cells. Mol. Cell. Biol. 2006; 26: 5850–5860
  • Bertina R.M., Koeleman B. P., Koster T., Rosendaal F. R., Dirven R. J., de R H, van d, V, Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994; 369: 64–67
  • Blum M., Grant D. M., McBride W., Heim M., Meyer U. A. Human Arylamine N-Acetyltransferase genes: Isolation, chromosomal localization, and functional expression. DNA Cell. Biol. 1990; 9: 193–203
  • Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G. F., Lucarelli P., Pellecchia M., Eisenbarth G. S., Comings D., Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with Type I diabetes. Nat. Genet. 2004; 36: 337–338
  • Brena R. M., Huang T. H., Plass C. Toward a human epigenome. Nat. Genet. 2006; 38: 1359–1360
  • Buch S., Schafmayer C., Volzke H., Becker C., Franke A., von Eller-Eberstein H., Kluck C., Bassmann I., Brosch M., Lammert F., Miquel J. F., Nervi F., Wittig M., Rosskopf D., Timm B., Holl C., Seeger M., El Sharawy A., Lu T., Egberts J., Fandrich F., Folsch U. R., Krawczak M., Schreiber S., Nurnberg P., Tepel J., Hampe J. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat. Genet. 2007; 39: 995–999
  • Burghes A. H., Vaessin H. E., de La C A. The land between Mendelian and multifactorial inheritance. Science 2001; 293: 2213–2214
  • Campbell C. D., Ogburn E. L., Lunetta K. L., Lyon H. N., Freedman M. L., Groop L. C., Altshuler D., Ardlie K. G., Hirschhorn J. N. Demonstrating stratification in a European American population. Nat. Genet. 2005; 37: 868–872
  • Carrasquillo M. M., McCallion A. S., Puffenberger E. G., Kashuk C. S., Nouri N., Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat. Genet. 2002; 32: 237–244
  • Cartegni L., Chew S. L., Krainer A. R. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 2002; 3: 285–298
  • Chanock S. J., Manolio T., Boehnke M., Boerwinkle E., Hunter D. J., Thomas G., Hirschhorn J. N., Abecasis G., Altshuler D., Bailey-Wilson J. E., Brooks L. D., Cardon L. R., Daly M., Donnelly P., Fraumeni J. F., Jr., Freimer N. B., Gerhard D. S., Gunter C., Guttmacher A. E., Guyer M. S., Harris E. L., Hoh J., Hoover R., Kong C. A., Merikangas K. R., Morton C. C., Palmer L. J., Phimister E. G., Rice J. P., Roberts J., Rotimi C., Tucker M. A., Vogan K. J., Wacholder S., Wijsman E. M., Winn D. M., Collins F. S. Replicating genotype-phenotype associations. Nature 2007; 447: 655–660
  • Chao H. K., Hsiao K. J., Su T. S. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum. Genet. 2001; 108: 14–19
  • Chaudhary S., Behari M., Dihana M., Swaminath P. V., Govindappa S. T., Jayaram S., Singh S., Muthane U. B., Juyal R. C., B K T. Association of N-Acetyl transferase-2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson Disease among Indians. Pharmacogenet. Genomics 2005; 15: 731–735
  • Chen K., Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 2006; 38: 1452–1456
  • Chen X., Wang L., Zhi L., Zhou G., Wang H., Zhang X., Hao B., Zhu Y., Cheng Z., He F. The -113G>A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin. Pharmacol. Ther. 2005; 78: 249–259
  • Choi J. H., Ahn B. M., Yi J., Lee J. H., Lee J. H., Nam S. W., Chon C. Y., Han K. H., Ahn S. H., Jang I. J., Cho J. Y., Suh Y., Cho M. O., Lee J. E., Kim K. H., Lee M. G. MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics 2007; 17: 403–415
  • Clark A. G., Boerwinkle E., Hixson J., Sing C. F. Determinants of the success of whole-genome association testing. Genome Res. 2005; 15: 1463–1467
  • Conrad D. F., Jakobsson M., Coop G., Wen X., Wall J. D., Rosenberg N. A., Pritchard J. K. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat. Genet. 2006; 38: 1251–1260
  • Cooper G. M., Nickerson D. A., Eichler E. E. Mutational and selective effects on copy-number variants in the human genome. Nat. Genet. 2007; 39: 522–529
  • Cornelis M. C., El-Sohemy A., Kabagambe E. K., Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006; 295: 1135–1141
  • Cotton R. G. Heterogeneity of phenylketonuria at the clinical, protein and DNA levels. J. Inherit. Metab. Dis. 1990; 13: 739–750
  • Cox A., Dunning A. M., Garcia-Closas M., Balasubramanian S., Reed M. W., Pooley K. A., Scollen S., Baynes C., Ponder B. A., Chanock S., Lissowska J., Brinton L., Peplonska B., Southey M. C., Hopper J. L., McCredie M. R., Giles G. G., Fletcher O., Johnson N., dos S S, I, Gibson L., Bojesen S. E., Nordestgaard B. G., Axelsson C. K., Torres D., Hamann U., Justenhoven C., Brauch H., Chang-Claude J., Kropp S., Risch A., Wang-Gohrke S., Schurmann P., Bogdanova N., Dork T., Fagerholm R., Aaltonen K., Blomqvist C., Nevanlinna H., Seal S., Renwick A., Stratton M. R., Rahman N., Sangrajrang S., Hughes D., Odefrey F., Brennan P., Spurdle A. B., Chenevix-Trench G., Beesley J., Mannermaa A., Hartikainen J., Kataja V., Kosma V. M., Couch F. J., Olson J. E., Goode E. L., Broeks A., Schmidt M. K., Hogervorst F. B., Van't Veer L. J., Kang D., Yoo K. Y., Noh D. Y., Ahn S. H., Wedren S., Hall P., Low Y. L., Liu J., Milne R. L., Ribas G., Gonzalez-Neira A., Benitez J., Sigurdson A. J., Stredrick D. L., Alexander B. H., Struewing J. P., Pharoah P. D., Easton D. F. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 2007; 39: 352–358
  • de Bakker P. I., Burtt N. P., Graham R. R., Guiducci C., Yelensky R., Drake J. A., Bersaglieri T., Penney K. L., Butler J., Young S., Onofrio R. C., Lyon H. N., Stram D. O., Haiman C. A., Freedman M. L., Zhu X., Cooper R., Groop L., Kolonel L. N., Henderson B. E., Daly M. J., Hirschhorn J. N., Altshuler D. Transferability of tag SNPs in genetic association studies in multiple populations. Nat. Genet. 2006; 38: 1298–1303
  • Draper N., Walker E. A., Bujalska I. J., Tomlinson J. W., Chalder S. M., Arlt W., Lavery G. G., Bedendo O., Ray D. W., Laing I., Malunowicz E., White P. C., Hewison M., Mason P. J., Connell J. M., Shackleton C. H., Stewart P. M. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase Type-1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat. Genet. 2003; 34: 434–439
  • Dubourg C., Lazaro L., Pasquier L., Bendavid C., Blayau M., Le D. F., Durou M. R., Odent S., David V. Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlations. Hum. Mutat. 2004; 24: 43–51
  • Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J., Steinhart A. H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L. W., Kistner E. O., Schumm L. P., Lee A. T., Gregersen P. K., Barmada M. M., Rotter J. I., Nicolae D. L., Cho J. H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461–1463
  • Easton D. F., Pooley K. A., Dunning A. M., Pharoah P. D., Thompson D., Ballinger D. G., Struewing J. P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C. S., Bowman R., Meyer K. B., Haiman C. A., Kolonel L. K., Henderson B. E., Le M. L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C. Y., Wu P. E., Wang H. C., Eccles D., Evans D. G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M. R., Rahman N., Chenevix-Trench G., Bojesen S. E., Nordestgaard B. G., Axelsson C. K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K. Y., Noh D. Y., Ahn S. H., Hunter D. J., Hankinson S. E., Cox D. G., Hall P., Wedren S., Liu J., Low Y. L., Bogdanova N., Schurmann P., Dork T., Tollenaar R. A., Jacobi C. E., Devilee P., Klijn J. G., Sigurdson A. J., Doody M. M., Alexander B. H., Zhang J., Cox A., Brock I. W., MacPherson G., Reed M. W., Couch F. J., Goode E. L., Olson J. E., Meijers-Heijboer H., van den O. A., Uitterlinden A., Rivadeneira F., Milne R. L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J. L., McCredie M., Southey M., Giles G. G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y. D., Spurdle A. B., Beesley J., Chen X., Mannermaa A., Kosma V. M., Kataja V., Hartikainen J., Day N. E., Cox D. R., Ponder B. A. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087–1093
  • Eaton D. L., Gallagher E. P., Bammler T. K., Kunze K. L. Role of cytochrome P450 1A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity. Pharmacogenetics 1995; 5: 259–274
  • Eberle M. A., Pauline N. G., Kuhn K., Zhou L., Peiffer D. A., Galver L., Viaud-Martinez K. A., Taylor C., Gunderson K. L., Shen R., Murray S. S. Power to detect risk alleles using genome-wide tag-SNP panels. PLoS Genet 2007; 3: ePub
  • Eberle M. A., Rieder M. J., Kruglyak L., Nickerson D. A. Allele frequency matching between SNPs reveals an excess of linkage disequilibrium in genic regions of the human genome. PLoS Genet 2006; 2: e142
  • Eckhardt F., Lewin J., Cortese R., Rakyan V. K., Attwood J., Burger M., Burton J., Cox T. V., Davies R., Down T. A., Haefliger C., Horton R., Howe K., Jackson D. K., Kunde J., Koenig C., Liddle J., Niblett D., Otto T., Pettett R., Seemann S., Thompson C., West T., Rogers J., Olek A., Berlin K., Beck S. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 2006; 38: 1378–1385
  • Ege M. J., Bieli C., Frei R., van Strien R. T., Riedler J., Ublagger E., Schram-Bijkerk D., Brunekreef B., van H. M., Scheynius A., Pershagen G., Benz M. R, Lauener R., von M. E., Braun-Fahrlander C. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol. 2006; 117: 817–823
  • Eichelbaum M. Polymorphic drug oxidation in humans. Fed. Proc. 1984; 43: 2298–2302
  • Eichelbaum M., Ingelman-Sundberg M., Evans W. E. Pharmacogenomics and individualized drug therapy. Annu. Rev. Med. 2006; 57: 119–137
  • Eichelbaum M., Spannbrucker N., Steincke B., Dengler H. J. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur. J. Clin. Pharmacol. 1979; 16: 183–187
  • Evans D. A., Manley K. A., McKusick V. A. Genetic control of isoniazid metabolism in man. Br. Med. J. 1960; 2: 485–491
  • Feinberg A. P. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447: 433–440
  • Fellay J., Shianna K. V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagnam A., Cossarizza A., Cozzi-Lepri A., de la, Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J. M., Obel N., Smith J. P., Wyniger J., Descombes P., Antonarakis S. E., Letvin N. L., McMichael A. J., Haynes B. F., Telenti A., Goldstein D. B. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944–947
  • Frayling T. M., Timpson N. J., Weedon M. N., Zeggini E., Freathy R. M., Lindgren C. M., Perry J. R., Elliott K. S., Lango H., Rayner N. W., Shields B., Harries L. W., Barrett J. C., Ellard S., Groves C. J., Knight B., Patch A. M., Ness A. R., Ebrahim S., Lawlor D. A., Ring S. M., Ben-Shlomo Y., Jarvelin M. R., Sovio U., Bennett A. J., Melzer D., Ferrucci L., Loos R. J., Barroso I., Wareham N. J., Karpe F., Owen K. R., Cardon L. R., Walker M., Hitman G. A., Palmer C. N., Doney A. S., Morris A. D., Smith G. D., Hattersley A. T., McCarthy M. I. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889–894
  • Freeman J. L., Perry G. H., Feuk L., Redon R., McCarroll S. A., Altshuler D. M., Aburatani H., Jones K. W., Tyler-Smith C., Hurles M. E., Carter N. P., Scherer S. W., Lee C. Copy number variation: New insights in genome diversity. Genome Res. 2006; 16: 949–961
  • Galindo M. I., Pueyo J. I., Fouix S., Bishop S. A., Couso J. P. Peptides encoded by short ORFs control development and define a new eukaryotic gene family. PLoS Biol. 2007; 5: e106
  • Gandhi T. K., Zhong J., Mathivanan S., Karthick L., Chandrika K. N., Mohan S. S., Sharma S., Pinkert S., Nagaraju S., Periaswamy B., Mishra G., Nandakumar K., Shen B., Deshpande N., Nayak R., Sarker M., Boeke J. D., Parmigiani G., Schultz J., Bader J. S., Pandey A. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat. Genet. 2006; 38: 285–293
  • Gerstein M. B., Bruce C., Rozowsky J. S., Zheng D., Du J., Korbel J. O., Emanuelsson O., Zhang Z. D., Weissman S., Snyder M. What is a gene, Post-ENCODE? History and updated definition. Genome Res. 2007; 17: 669–681
  • Gherman A., Chen P. E., Teslovich T. M., Stankiewicz P., Withers M., Kashuk C. S., Chakravarti A., Lupski J. R., Cutler D. J., Katsanis N. Population bottlenecks as a potential major shaping force of human genome architecture. PLoS Genet. 2007; 3: e119
  • Gibbs J. R., Singleton A. Application of genome-wide single nucleotide polymorphism typing: Simple association and beyond. PLoS Genet. 2006; 2: e150
  • Gibbs R. A., et al. The International HapMap Project. Nature 2003; 426: 789–796, (The International HapMap Consortium)
  • Gingeras T. R. Origin of phenotypes: Genes and transcripts. Genome Res. 2007; 17: 682–690
  • Goldman R. D., Shumaker D. K., Erdos M. R., Eriksson M., Goldman A. E., Gordon L. B., Gruenbaum Y., Khuon S., Mendez M., Varga R., Collins F. S. Accumulation of mutant Lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford Progeria syndrome. Proc. Natl. Acad. Sci. USA 2004; 101: 8963–8968
  • Goldstein J. A., de Morais S. M. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 1994; 4: 285–299
  • Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442–446
  • Grace M. E., Balwani M., Nazarenko I., Prakash-Cheng A., Desnick R. J. Type 1 Gaucher Disease: Null and hypomorphic novel chitotriosidase mutations—implications for diagnosis and therapeutic monitoring. Hum. Mutat. 2007; 28: 866–873
  • Grant S. F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K. P., Walters G. B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J. R., Kong A., Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of Type 2 diabetes. Nat. Genet. 2006; 38: 320–323
  • Greenbaum L., Strous R. D., Kanyas K., Merbl Y., Horowitz A., Karni O., Katz E., Kotler M., Olender T., Deshpande S. N., Lancet D., Ben-Asher E., Lerer B. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenet. Genomics 2007; 17: 519–528
  • Gretarsdottir S., Thorleifsson G., Reynisdottir S. T., Manolescu A., Jonsdottir S., Jonsdottir T., Gudmundsdottir T., Bjarnadottir S. M., Einarsson O. B., Gudjonsdottir H. M., Hawkins M., Gudmundsson G., Gudmundsdottir H., Andrason H., Gudmundsdottir A. S., Sigurdardottir M., Chou T. T., Nahmias J., Goss S., Sveinbjornsdottir S., Valdimarsson E. M., Jakobsson F., Agnarsson U., Gudnason V., Thorgeirsson G., Fingerle J., Gurney M., Gudbjartsson D., Frigge M. L., Kong A., Stefansson K., Gulcher J. R. The gene encoding phosphodiesterase 4D confers risk of ischemic atroke. Nat. Genet. 2003; 35: 131–138
  • Grossman I., Avidan N., Singer C., Goldstaub D., Hayardeny L., Eyal E., Ben-Asher E., Paperna T., Pe'er I., Lancet D., Beckmann J. S., Miller A. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers. Pharmacogenet. Genomics 2007; 17: 657–666
  • Gudmundsson J., Sulem P., Manolescu A., Amundadottir L. T., Gudbjartsson D., Helgason A., Rafnar T., Bergthorsson J. T., Agnarsson B. A., Baker A., Sigurdsson A., Benediktsdottir K. R., Jakobsdottir M., Xu J., Blondal T., Kostic J., Sun J., Ghosh S., Stacey S. N., Mouy M., Saemundsdottir J., Backman V. M., Kristjansson K., Tres A., Partin A. W., bers-Akkers M. T., Godino-Ivan M. J., Walsh P. C., Swinkels D. W., Navarrete S., Isaacs S. D., Aben K. K., Graif T., Cashy J., Ruiz-Echarri M., Wiley K. E., Suarez B. K., Witjes J. A., Frigge M., Ober C., Jonsson E., Einarsson G. V., Mayordomo J. I., Kiemeney L. A., Isaacs W. B., Catalona W. J., Barkardottir R. B., Gulcher J. R., Thorsteinsdottir U., Kong A., Stefansson K. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 2007a; 39: 631–637
  • Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J. T., Thorleifsson G., Manolescu A., Rafnar T., Gudbjartsson D., Agnarsson B. A., Baker A., Sigurdsson A., Benediktsdottir K. R., Jakobsdottir M., Blondal T., Stacey S. N., Helgason A., Gunnarsdottir S., Olafsdottir A., Kristinsson K. T., Birgisdottir B., Ghosh S., Thorlacius S., Magnusdottir D., Stefansdottir G., Kristjansson K., Bagger Y., Wilensky R. L., Reilly M. P., Morris A. D., Kimber C. H., Adeyemo A., Chen Y., Zhou J., So W. Y., Tong P. C., Ng M. C., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Tres A., Fuertes F., Ruiz-Echarri M., Asin L., Saez B., van B. E., Klaver S., Swinkels D. W., Aben K. K., Graif T., Cashy J., Suarez B. K., van Vierssen T. O., Frigge M. L., Ober C., Hofker M. H., Wijmenga C., Christiansen C., Rader D. J., Palmer C. N., Rotimi C., Chan J. C., Pedersen O., Sigurdsson G., Benediktsson R., Jonsson E., Einarsson G. V., Mayordomo J. I., Catalona W. J., Kiemeney L. A., Barkardottir R. B., Gulcher J. R., Thorsteinsdottir U., Kong A., Stefansson K. Two variants on Chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against Type 2 diabetes. Nat. Genet. 2007b; 39: 977–983
  • Hakonarson H., Grant S. F., Bradfield J. P., Marchand L., Kim C. E., Glessner J. T., Grabs R., Casalunovo T., Taback S. P., Frackelton E. C., Lawson M. L., Robinson L. J., Skraban R., Lu Y., Chiavacci R. M., Stanley C. A., Kirsch S. E., Rappaport E. F., Orange J. S., Monos D. S., Devoto M., Qu H. Q., Polychronakos C. A genome-wide association study identifies KIAA0350 as a Type 1 diabetes gene. Nature 2007; 448: 591–594
  • Han S. W., Jeon Y. K., Lee K. H., Keam B., Hwang P. G., Oh D. Y., Lee S. H., Kim D. W., Im S. A., Chung D. H., Heo D. S., Bang Y. J., Kim T. Y. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer. Pharmacogenet. Genomics 2007; 17: 313–319
  • Hauner H., Meier M., Jockel K. H., Frey U. H., Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-Protein B3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13: 453–459
  • Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., Jonasdottir A., Sigurdsson A., Baker A., Palsson A., Masson G., Gudbjartsson D. F., Magnusson K. P., Andersen K., Levey A. I., Backman V. M., Matthiasdottir S., Jonsdottir T., Palsson S., Einarsdottir H., Gunnarsdottir S., Gylfason A., Vaccarino V., Hooper W. C., Reilly M. P., Granger C. B., Austin H., Rader D. J., Shah S. H., Quyyumi A. A., Gulcher J. R., Thorgeirsson G., Thorsteinsdottir U., Kong A., Stefansson K. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491–1493
  • Hirschhorn J. N., Lohmueller K., Byrne E., Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 2002; 4: 45–61
  • Ho Y., Elefant F., Liebhaber S. A., Cooke N. E. Locus control region transcription plays an active role in long-range gene activation. Mol. Cell 2006; 23: 365–375
  • Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cezard J. P., Belaiche J., Almer S., Tysk C., O'Morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J. F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
  • Hull J., Campino S., Rowlands K., Chan M. S., Copley R. R., Taylor M. S., Rockett K., Elvidge G., Keating B., Knight J., Kwiatkowski D. Identification of common genetic variation that modulates alternative splicing. PLoS Genet. 2007; 3: e99
  • Hunter D. J. Sharing the rankings. N. Engl. J. Med. 2007; 357: 437–439
  • Hunter D. J., Kraft P., Jacobs K. B., Cox D. G., Yeager M., Hankinson S. E., Wacholder S., Wang Z., Welch R., Hutchinson A., Wang J., Yu K., Chatterjee N., Orr N., Willett W. C., Colditz G. A., Ziegler R. G., Berg C. D., Buys S. S., McCarty C. A., Feigelson H. S., Calle E. E., Thun M. J., Hayes R. B., Tucker M., Gerhard D. S., Fraumeni J. F., Jr., Hoover R. N., Thomas G., Chanock S. J. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007; 39: 870–874
  • Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005; 5: 6–13
  • Ioannidis J. P. Genetic associations: False or true?. Trends Mol. Med. 2003; 9: 135–138
  • Ioannidis J. P., Ntzani E. E., Trikalinos T. A., Contopoulos-Ioannidis D. G. Replication validity of genetic association studies. Nat. Genet. 2001; 29: 306–309
  • Ioannidis J. P., Trikalinos T. A., Ntzani E. E., Contopoulos-Ioannidis D. G. Genetic associations in large versus small studies: An empirical assessment. Lancet 2003; 361: 567–571
  • Jansen G. A., Waterham H. R., Wanders R. J. Molecular basis of Refsum disease: Sequence variations in phytanoyl-coA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum. Mutat. 2004; 23: 209–218
  • Jiang Z., Dragin N., Jorge-Nebert L. F., Martin M. V., Guengerich F. P., Aklillu E., Ingelman-Sundberg M., Hammons G. J., Lyn-Cook B. D., Kadlubar F. F., Saldana S. N., Sorter M., Vinks A. A., Nassr N., von R. O., Jin L., Nebert D. W. Search for an association between the human CYP1A2 Genotype and CYP1A2 metabolic phenotype. Pharmacogenet. Genomics 2006; 16: 359–367
  • Kajiwara K., Berson E. L., Dryja T. P. Digenic retinitis pigmentosa due to mutations at the unlinked Peripherin/RDS and ROM1 loci. Science 1994; 264: 1604–1608
  • Kalow W. Contribution of hereditary factors to the response to drugs. Fed. Proc. 1965; 24: 1259–1265
  • Kalow W. Pharmacoanthropology: Drug Metabolism. Fed. Proc. 1984a; 43: 2326–2331
  • Kalow W. Pharmacoanthropology: Outline, problems, and the nature of case histories. Fed. Proc. 1984b; 43: 2314–2318
  • Kapranov P., Willingham A. T., Gingeras T. R. Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet. 2007; 8: 413–423
  • Katsanis N., Ansley S. J., Badano J. L., Eichers E. R., Lewis R. A., Hoskins B. E., Scambler P. J., Davidson W. S., Beales P. L., Lupski J. R. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 2001; 293: 2256–2259
  • Katzman S., Kern A. D., Bejerano G., Fewell G., Fulton L., Wilson R. K., Salama S. R., Haussler D. Human genome ultraconserved elements are ultraselected. Science 2007; 317: 915
  • Keene J. D. RNA regulons: Coordination of post-transcriptional events. Nat. Rev. Genet. 2007; 8: 533–543
  • Khaitovich P., Kelso J., Franz H., Visagie J., Giger T., Joerchel S., Petzold E., Green R. E., Lachmann M., Paabo S. Functionality of intergenic transcription: An evolutionary comparison. PLoS Genet. 2006; 2: e171
  • Khaja R, Zhang J., MacDonald J. R., He Y., Joseph-George A. M., Wei J., Rafiq M. A., Qian C., Shago M., Pantano L., Aburatani H., Jones K., Redon R., Hurles M., Armengol L., Estivill X., Mural R. J., Lee C., Scherer S. W., Feuk L. Genome assembly comparison identifies structural variants in the human genome. Nat. Genet. 2006; 38: 1413–1418
  • Kikuta H., Laplante M., Navratilova P., Komisarczuk A. Z., Engstrom P. G., Fredman D., Akalin A., Caccamo M., Sealy I., Howe K., Ghislain J., Pezeron G., Mourrain P., Ellingsen S., Oates A. C., Thisse C., Thisse B., Foucher I., Adolf B., Geling A., Lenhard B., Becker T. S. Genomic regulatory blocks encompass multiple neighboring genes and maintain conserved synteny in vertebrates. Genome Res. 2007; 17: 545–555
  • Kim S. H., Kim Y. K., Park H. W., Jee Y. K., Kim S. H., Bahn J. W., Chang Y. S., Kim S. H., Ye Y. M., Shin E. S., Lee J. E., Park H. S., Min K. U. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet. Genomics 2007; 17: 295–304
  • Kim U. K., Jorgenson E., Coon H., Leppert M., Risch N., Drayna D. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science 2003; 299: 1221–1225
  • Kingsmore S. F., Lindquist I. E., Mudge J., Beavis W. D. Genome-wide association studies: progress in identifying genetic biomarkers in common complex diseases. Biomarker Insights 2007; 2: 283–292
  • Klein R. J., Zeiss C., Chew E. Y., Tsai J. Y., Sackler R. S., Haynes C., Henning A. K., SanGiovanni J. P., Mane S. M., Mayne S. T., Bracken M. B., Ferris F. L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385–389
  • Knight R. A., Selin M. J., Harris H. W. Genetic factors influencing isoniazid blood levels in humans. Trans. Conf. Chemother. Tuberc. 1959; 8: 52–56
  • Kruglyak L., Nickerson D. A. Variation is the spice of life. Nat. Genet. 2001; 27: 234–236
  • Krynetski E. Y., Schuetz J. D., Galpin A. J., Pui C. H., Relling M. V., Evans W. E. A single-point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc. Natl. Acad. Sci. USA 1995; 92: 949–953
  • Kwan T., Benovoy D., Dias C., Gurd S., Serre D., Zuzan H., Clark T. A., Schweitzer A., Staples M. K., Wang H., Blume J. E., Hudson T. J., Sladek R., Majewski J. Heritability of alternative splicing in the human genome. Genome Res. 2007; 17: 1210–1218
  • La Du B. N. Altered drug response in hereditary disease. Fed. Proc. 1965; 24: 1287–1292
  • La Du B. N., Eckerson H. W. The polymorphic paraoxonase/arylesterase isozymes of human serum. Fed. Proc. 1984; 43: 2338–2341
  • Lamba J., Strom S., Venkataramanan R., Thummel K. E., Lin Y. S., Liu W., Cheng C., Lamba V., Watkins P. B., Schuetz E. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype. Clin. Pharmacol. Ther. 2006; 79: 325–338
  • Lee C. R., North K. E., Bray M. S., Couper D. J., Heiss G., Zeldin D. C. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: The Atherosclerosis Risk in Communities (ARIC) study. Pharmacogenet. Genomics 2007; 17: 349–358
  • Lesko L. J. Personalized medicine: Elusive dream or imminent reality?. Clin. Pharmacol. Ther. 2007; 81: 807–816
  • Levine E., Zhang Z., Kuhlman T., Hwa T. Quantitative characteristics of gene regulation by small RNA. PLoS Biol. 2007; 5: e229
  • Levy S., Sutton G., Ng P. C., Feuk L., Halpern A. L., Walenz B. P., Axelrod N., Huang J., Kirkness E. F., Denisov G., Lin Y., MacDonald J. R., Pang A. W., Shago M., Stockwell T. B., Tsiamouri A., Bafna V., Bansal V., Kravitz S. A., Busam D. A., Beeson K. Y., McIntosh T. C., Remington K. A., Abril J. F., Gill J., Borman J., Rogers Y. H., Frazier M. E., Scherer S. W., Strausberg R. L., Venter J. C. The diploid genome sequence of an individual human. PLoS Biol. 2007; 5: e254
  • Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., Vermeire S., Dewit O., de V. M., Dixon A., Demarche B., Gut I., Heath S., Foglio M., Liang L., Laukens D., Mni M., Zelenika D., Van G. A., Rutgeerts P., Belaiche J., Lathrop M., Georges M. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007; 3: e58
  • Lin Z., Walther D., Yu X. Y., Drgon T., Uhl G. R. The human serotonin receptor HTR2B: Coding region polymorphisms and association with vulnerability to illegal drug abuse. Pharmacogenetics 2004; 14: 805–811
  • Li Y. F., Langholz B., Salam M. T., Gilliland F. D. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest 2005; 127: 1232–1241
  • Locke D. P., Sharp A. J., McCarroll S. A., McGrath S. D., Newman T. L., Cheng Z., Schwartz S., Albertson D. G., Pinkel D., Altshuler D. M., Eichler E. E. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am. J. Hum. Genet. 2006; 79: 275–290
  • Lomvardas S., Barnea G., Pisapia D. J., Mendelsohn M., Kirkland J., Axel R. Interchromosomal interactions and olfactory receptor choice. Cell 2006; 126: 403–413
  • Long X., Miano J. M. Remote control of gene expression. J. Biol. Chem. 2007; 282: 15941–15945
  • Lowe C. E., Cooper J. D., Brusko T., Walker N. M., Smyth D. J., Bailey R., Bourget K., Plagnol V., Field S., Atkinson M., Clayton D. G., Wicker L. S., Todd J. A. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in Type 1 diabetes. Nat. Genet. 2007; 39: 1074–1082
  • Ma H., Xu L., Yuan J., Shao M., Hu Z., Wang F., Wang Y., Yuan W., Qian J., Wang Y., Xun P., Liu H., Chen W., Yang L., Jin G., Huo X., Chen F., Shugart Y. Y., Jin L., Wei Q., Wu T., Shen H., Huang W., Lu D. Tagging single nucleotide polymorphisms in excision repair cross-complementing Group 1 (ERCC1) and risk of primary lung cancer in a Chinese population. Pharmacogenet. Genomics 2007; 17: 417–423
  • Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of debrisoquine in man. Lancet 1977; 2: 584–586
  • Mailman M. D., Feolo M., Jin Y., Kimura M., Tryka K., Bagoutdinov R., Hao L., Kiang A., Paschall J., Phan L., Popova N., Pretel S., Ziyabari L., Lee M., Shao Y., Wang Z. Y., Sirotkin K., Ward M., Kholodov M., Zbicz K., Beck J., Kimelman M., Shevelev S., Preuss D., Yaschenko E., Graeff A., Ostell J., Sherry S. T. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 2007; 39: 1181–1186
  • Manica A., Amos W., Balloux F., Hanihara T. The effect of ancient population bottlenecks on human phenotypic variation. Nature 2007; 448: 346–348
  • Maraganore D. M., de A. M., Lesnick T. G., Strain K. J., Farrer M. J., Rocca W. A., Pant P. V., Frazer K. A., Cox D. R., Ballinger D. G. High-resolution whole-genome association study of Parkinson Disease. Am. J. Hum. Genet. 2005; 77: 685–693
  • Marino C., Giorda R., Luisa L. M., Vanzin L., Salandi N., Nobile M., Citterio A., Beri S., Crespi V., Battaglia M., Molteni M. A family-based association study does not support DYX1C1 on 15q21.3 as a candidate gene in developmental dyslexia. Eur. J. Hum. Genet. 2005; 13: 491–499
  • Martin C, Zhang Y. Mechanisms of epigenetic inheritance. Curr. Opin. Cell Biol. 2007; 19: 266–272
  • Marvit J., DiLella A. G., Brayton K., Ledley F. D., Robson K. J., Woo S. L. GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria. Nucleic Acids Res. 1987; 15: 5613–5628
  • McEwen G. K., Woolfe A., Goode D., Vavouri T., Callaway H., Elgar G. Ancient duplicated conserved noncoding elements in vertebrates: A genomic and functional analysis. Genome Res. 2006; 16: 451–465
  • McKusick V. A. The Gordon Wilson Lecture: The clinical legacy of Jonathan Hutchinson (1828–1913): Syndromology and dysmorphology meet genomics. Trans. Am. Clin. Climatol. Assoc. 2005; 116: 15–38
  • McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D. R., Hinds D. A., Pennacchio L. A., Tybjaerg-Hansen A., Folsom A. R., Boerwinkle E., Hobbs H. H., Cohen J. C. A common allele on Chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488–1491
  • McVean G., Spencer C. C., Chaix R. Perspectives on human genetic variation from the HapMap Project. PLoS Genet. 2005; 1: e54
  • Medici M., van Meurs J. B., Rivadeneira F., Zhao H., Arp P. P., Hofman A., Pols H. A., Uitterlinden A. G. BMP2 gene polymorphisms and osteoporosis: The Rotterdam Study. J. Bone Miner. Res. 2006; 21: 845–854
  • Mekus F., Laabs U., Veeze H., Tummler B. Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs. Hum. Genet. 2003; 112: 1–11
  • Meng H., Hager K., Held M., Page G. P., Olson R. K., Pennington B. F., DeFries J. C., Smith S. D., Gruen J. R. TDT-association analysis of EKN1 and dyslexia in a Colorado twin cohort. Hum. Genet. 2005; 118: 87–90
  • Metzger S., Bauer P., Tomiuk J., Laccone F., Didonato S., Gellera C., Mariotti C., Lange H. W., Weirich-Schwaiger H., Wenning G. K., Seppi K., Melegh B., Havasi V., Baliko L., Wieczorek S., Zaremba J., Hoffman-Zacharska D., Sulek A., Basak A. N., Soydan E., Zidovska J., Kebrdlova V., Pandolfo M., Ribai P., Kadasi L., Kvasnicova M., Weber B. H., Kreuz F., Dose M., Stuhrmann M., Riess O. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Hum. Genet. 2006; 120: 285–292
  • Mignot E. A step forward for restless legs syndrome. Nat. Genet. 2007; 39: 938–939
  • Ming J. E., Muenke M. Multiple hits during early embryonic development: Digenic diseases and holoprosencephaly. Am. J. Hum. Genet. 2002; 71: 1017–1032
  • Moffatt M. F., Kabesch M., Liang L., Dixon A. L., Strachan D., Heath S., Depner M., von Berg A., Bufe A., Rietschel E., Heinzmann A., Simma B., Frischer T., Willis-Owen S. A., Wong K. C., Illig T., Vogelberg C., Weiland S. K., von Mutius E., Abecasis G. R., Farrall M., Gut I. G., Lathrop G. M., Cookson W. O. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448: 470–473
  • Morton L. M., Wang S. S., Bergen A. W., Chatterjee N., Kvale P., Welch R., Yeager M., Hayes R. B., Chanock S. J., Caporaso N. E. DRD2 Genetic variation in relation to smoking and obesity in the prostate, lung, colorectal, and ovarian cancer screening trial. Pharmacogenet. Genomics 2006; 16: 901–910
  • Motulsky A. G. Drug reactions enzymes, and biochemical genetics. J. Am. Med. Assoc. 1957; 165: 835–837
  • Myers R. H. Considerations for genomewide association studies in Parkinson Disease. Am. J. Hum. Genet. 2006; 78: 1081–1082
  • Nakajima M., Yokoi T., Mizutani M., Kinoshita M., Funayama M., Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans. J. Biochem. (Tokyo) 1999; 125: 803–808
  • Nakamura S., Kugiyama K., Sugiyama S., Miyamoto S., Koide S., Fukushima H., Honda O., Yoshimura M., Ogawa H. Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002; 105: 2968–2973
  • Nebert D. W. Pharmacogenetics: 65 candles on the cake. Pharmacogenetics 1997; 7: 435–440
  • Nebert D. W. Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 1991; 5: 1203–1214
  • Nebert DW. Extreme discordant phenotype methodology: An intuitive approach to clinical pharmacogenetics. Eur. J. Pharmacol. 2000b; 410: 107–120
  • Nebert D. W. Inter-individual susceptibility to environmental toxicants—A current assessment. Toxicol. Appl. Pharmacol. 2005; 207: 34–42
  • Nebert D. W. Suggestions for the nomenclature of human alleles: Relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics 2000a; 10: 279–290
  • Nebert D. W., Dalton T. P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 2006; 6: 947–960
  • Nebert D. W., Ingelman-Sundberg M., Daly A. K. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab. Rev. 1999; 31: 467–487
  • Nebert D. W., Jorge-Nebert L., Vesell E. S. Pharmacogenomics and “individualized Drug Therapy”: High expectations and disappointing achievements. Am. J. Pharmacogenomics 2003; 3: 361–370
  • Nebert D. W., Robinson J. R., Niwa A., Kumaki K., Poland A. P. Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. J Cell Physiol 1975; 85: 393–414
  • Nebert D. W., Vesell E. S. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. Eur. J. Pharmacol. 2004; 500: 267–280
  • Need A. C., Goldstein D. B. Genome-wide tagging for everyone. Nat. Genet. 2006; 38: 1227–1228
  • Nishikura K. Editor meets silencer: Crosstalk between RNA editing and RNA interference. Nat. Rev. Mol. Cell Biol. 2006; 7: 919–931
  • Nomura M., Shigematsu H., Li L., Suzuki M., Takahashi T., Estess P., Siegelman M., Feng Z., Kato H., Marchetti A., Shay J. W., Spitz M. R., Wistuba I. I., Minna J. D., Gazdar A. F. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med 2007; 4: e125
  • O'Reilly R. A., Aggeler P. M. Coumarin anticoagulant drugs: Hereditary resistance in man. Fed. Proc. 1965; 24: 1266–1273
  • Ohlendorff S. D., Tofteng C. L., Jensen J. E., Petersen S., Civitelli R., Fenger M., Abrahamsen B., Hermann A. P., Eiken P., Jrgensen N. R. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet. Genomics 2007; 17: 555–567
  • Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., Tanaka T. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 2002; 32: 650–654
  • Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., Tranebjaerg L., Konttinen Y., Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002; 71: 656–662
  • Pembrey M. E. Time to take epigenetic inheritance seriously. Eur. J. Hum. Genet. 2002; 10: 669–671
  • Polesskaya O. O., Sokolov B. P. Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 2002; 67: 812–822
  • Price A. L., Patterson N. J., Plenge R. M., Weinblatt M. E., Shadick N. A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2007; 38: 904–909
  • Rakyan V. K., Beck S. Epigenetic variation and inheritance in mammals. Curr. Opin. Genet. Dev. 2006; 16: 573–577
  • Redon R., Ishikawa S., Fitch K. R., Feuk L., Perry G. H., Andrews T. D., Fiegler H., Shapero M. H., Carson A. R., Chen W., Cho E. K., Dallaire S., Freeman J. L., Gonzalez J. R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J. R., Marshall C. R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M. J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D. F., Estivill X., Tyler-Smith C., Carter N. P., Aburatani H., Lee C., Jones K. W., Scherer S. W., Hurles M. E. Global variation in copy number in the human genome. Nature 2006; 444: 444–454
  • Reneland R. H., Mah S., Kammerer S., Hoyal C. R., Marnellos G., Wilson S. G., Sambrook P. N., Spector T. D., Nelson M. R., Braun A. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med. Genet. 2005; 6: 9
  • Rioux J. D., Xavier R. J., Taylor K. D., Silverberg M. S., Goyette P., Huett A., Green T., Kuballa P., Barmada M. M., Datta L. W., Shugart Y. Y., Griffiths A. M., Targan S. R., Ippoliti A. F., Bernard E. J., Mei L., Nicolae D. L., Regueiro M., Schumm L. P., Steinhart A. H., Rotter J. I., Duerr R. H., Cho J. H., Daly M. J., Brant S. R. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007; 39: 596–604
  • Risch N., Merikangas K. The future of genetics studies of complex human diseases. Science 1996; 273: 1516–1517
  • Risch N. J. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847–856
  • Roach J. C., Deutsch K., Li S., Siegel A. F., Bekris L. M., Einhaus D. C., Sheridan C. M., Glusman G., Hood L., Lernmark A., Janer M. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor-3 as a risk factor for type-1 diabetes in Sweden. Am. J. Hum. Genet. 2006; 79: 614–627
  • Roden D. M., Altman R. B., Benowitz N. L., Flockhart D. A., Giacomini K. M., Johnson J. A., Krauss R. M., McLeod H. L., Ratain M. J., Relling M. V., Ring H. Z., Shuldiner A. R., Weinshilboum R. M., Weiss S. T. Pharmacogenomics: Challenges and opportunities. Ann. Intern. Med. 2006; 145: 749–757
  • Rosand J., Bayley N., Rost N., de Bakker P. I. Many hypotheses but no replication for the association between PDE4D and stroke. Nat. Genet. 2006; 38: 1091–1092
  • Roses A. “Personalized medicine: Elusive dream or imminent reality?” A commentary. Clin. Pharmacol. Ther. 2007; 81: 801–805
  • Rosvold E. A., McGlynn K. A., Lustbader E. D., Buetow K. H. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 1995; 5: 199–206
  • Sai K., Saeki M., Saito Y., Ozawa S., Katori N., Jinno H., Hasegawa R., Kaniwa N., Sawada J., Komamura K., Ueno K., Kamakura S., Kitakaze M., Kitamura Y., Kamatani N., Minami H., Ohtsu A., Shirao K., Yoshida T., Saijo N. UGT1A1 Haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin. Pharmacol. Ther. 2004; 75: 501–515
  • Samani N. J., Erdmann J., Hall A. S., Hengstenberg C., Mangino M., Mayer B., Dixon R. J., Meitinger T., Braund P., Wichmann H. E., Barrett J. H., Konig I. R., Stevens S. E., Szymczak S., Tregouet D. A., Iles M. M., Pahlke F., Pollard H., Lieb W., Cambien F., Fischer M., Ouwehand W., Blankenberg S., Balmforth A. J., Baessler A., Ball S. G., Strom T. M., Braenne I., Gieger C., Deloukas P., Tobin M. D., Ziegler A., Thompson J. R., Schunkert H. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 2007; 357: 443–453
  • San Millan J. L., Botella-Carretero J. I., varez-Blasco F., Luque-Ramirez M., Sancho J., Moghetti P., Escobar-Morreale H. F. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-hydroxysteroid dehydrogenase Type-1 Gene 83557insA polymorphisms in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2005; 90: 4157–4162
  • Sandhu M. S., Weedon M. N., Fawcett K. A., Wasson J., Debenham S. L., Daly A., Lango H., Frayling T. M., Neumann R. J., Sherva R., Blech I., Pharoah P. D., Palmer C. N., Kimber C., Tavendale R., Morris A. D., McCarthy M. I., Walker M., Hitman G., Glaser B., Permutt M. A., Hattersley A. T., Wareham N. J., Barroso I. Common variants in WFS1 confer risk of Type 2 diabetes. Nat. Genet. 2007; 39: 951–953
  • Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer disease. Neurology 1993; 43: 1467–1472
  • Scerri T. S., Fisher S. E., Francks C., MacPhie I. L., Paracchini S., Richardson A. J., Stein J. F., Monaco A. P. Putative functional alleles of DYX1C1 are not associated with dyslexia susceptibility in a large sample of sibling pairs from the UK. J. Med. Genet. 2004; 41: 853–857
  • Scheper G. C., van der Knaap M. S., Proud C. G. Translation matters: Protein synthesis defects in inherited disease. Nat. Rev. Genet. 2007; 8: 711–723
  • Schumacher J., Hoffmann P., Schmal C., Schulte-Korne G., Nothen M. M. Genetics of dyslexia: The evolving landscape. J. Med. Genet. 2007; 44: 289–297
  • Scriver C. R. The PAH gene, phenylketonuria, and a paradigm shift. Hum. Mutat. 2007; 28: 831–845
  • Scuteri A., Sanna S., Chen W. M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orru M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G. B., Fink A. A., Weder A. B., Cooper R. S., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta E., Abecasis G. R. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3: e115
  • Sebat J. Major changes in our DNA lead to major changes in our thinking. Nat. Genet. 2007; 39: S3–S5
  • Seidegård J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751–753
  • Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T. J., Montpetit A., Pshezhetsky A. V., Prentki M., Posner B. I., Balding D. J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for Type 2 diabetes. Nature 2007; 445: 881–885
  • Small K. M., Wagoner L. E., Levin A. M., Kardia S. L., Liggett S. B. Synergistic polymorphisms of B1- and A2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 2002; 347: 1135–1142
  • Snyder L. H. Studies in human inheritance. IX. The inheritance of taste deficiency in man. Ohio J. Sci. 1932; 32: 436–468
  • Spielberg S. P. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed. Proc. 1984; 43: 2308–2313
  • Spielman R. S., Bastone L. A., Burdick J. T., Morley M., Ewens W. J., Cheung V. G. Common genetic variants account for differences in gene expression among ethnic groups. Nat. Genet. 2007; 39: 226–231
  • Sriramm G., Martinez J. A., McCabe E. R., Liao J. C., Dipple K. M. Single-gene disorders: What role could moonlighting enzymes play?. Am. J. Hum. Genet. 2005; 76: 911–924
  • Stranger B. E., Forrest M. S., Dunning M., Ingle C. E., Beazley C., Thorne N., Redon R., Bird C. P., de G. A., Lee C., Tyler-Smith C., Carter N., Scherer S. W., Tavare S., Deloukas P., Hurles M. E., Dermitzakis E. T. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007a; 315: 848–853
  • Stranger B. E., Nica A. C., Forrest M. S., Dimas A., Bird C. P., Beazley C., Ingle C. E., Dunning M., Flicek P., Koller D., Montgomery S., Tavare S., Deloukas P., Dermitzakis E. T. Population genomics of human gene expression. Nat. Genet. 2007b; 39: 1217–1224
  • Styrkarsdottir U., Cazier J. B., Kong A., Rolfsson O., Larsen H., Bjarnadottir E., Johannsdottir V. D., Sigurdardottir M. S., Bagger Y., Christiansen C., Reynisdottir I., Grant S. F., Jonasson K., Frigge M. L., Gulcher J. R., Sigurdsson G., Stefansson K. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 2003; 1: E69
  • Swen J. J., Huizinga T. W., Gelderblom H., de Vries E. G., Assendelft W. J., Kirchheiner J., Guchelaar H. J. Translating pharmacogenomics: Challenges on the road to the clinic. PLoS Med. 2007; 4: e209
  • Taipale M., Kaminen N., Nopola-Hemmi J., Haltia T., Myllyluoma B., Lyytinen H., Muller K., Kaaranen M., Lindsberg P. J., Hannula-Jouppi K., Kere J. A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain. Proc. Natl. Acad. Sci. USA 2003; 100: 11553–11558
  • Takeda H., Caiment F., Smit M., Hiard S., Tordoir X., Cockett N., Georges M., Charlier C. The Callipyge mutation enhances bidirectional long-range DLK1-GTL2 intergenic transcription in Cis. Proc. Natl. Acad. Sci. USA 2006; 103: 8119–8124
  • Tanner C. M., Ottman R., Goldman S. M., Ellenberg J., Chan P., Mayeux R., Langston J. W. Parkinson disease in twins: An etiologic study. J. Am. Med. Assn. 1999; 281: 341–346
  • Tate S. K., Goldstein D. B. Will tomorrow's medicines work for everyone?. Nat. Genet. 2004; 36: S34–S42
  • The ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE Pilot Project. Nature 2007; 447: 799–816
  • The ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) project. Science 2004; 306: 636–640
  • The GAIN Collaborative Research Group. New models of collaboration in genome-wide association studies: the genetic association information network. Nat. Genet. 2007; 39: 1045–1051
  • The International HapMap Consortium. A Haplotype map of the human genome. Nature 2005; 437: 1299–1320
  • The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–678
  • Thomas D. C., Haile R. W., Duggan D. Recent developments in genomewide association scans: A workshop summary and review. Am. J. Hum. Genet. 2005; 77: 337–345
  • Tomlinson I., Webb E., Carvajal-Carmona L., Broderick P., Kemp Z., Spain S., Penegar S., Chandler I., Gorman M., Wood W., Barclay E., Lubbe S., Martin L., Sellick G., Jaeger E., Hubner R., Wild R., Rowan A., Fielding S., Howarth K., Silver A., Atkin W., Muir K., Logan R., Kerr D., Johnstone E., Sieber O., Gray R., Thomas H., Peto J., Cazier J. B., Houlston R. A genome-wide association scan of Tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007; 39: 984–988
  • Vagin V. V., Sigova A., Li C., Seitz H., Gvozdev V., Zamore P. D. A distinct small RNA pathway silences selfish genetic elements in the germline. Science 2006; 313: 320–324
  • Valdar W., Solberg L. C., Gauguier D., Burnett S., Klenerman P., Cookson W. O., Taylor M. S., Rawlins J. N., Mott R., Flint J. Genome-wide genetic association of complex traits in heterogeneous-stock mice. Nat. Genet. 2006; 38: 879–887
  • van Aken J., Schmedders M., Feuerstein G., Kollek R. Prospects and limits of pharmacogenetics: The thiopurine methyltransferase (TPMT) experience. Am. J. Pharmacogenomics 2003; 3: 147–155
  • van den Brink D. M., Brites P., Haasjes J., Wierzbicki A. S., Mitchell J., Lambert-Hamill M., de B. J., Jansen G. A., Waterham H. R., Wanders R. J. Identification of PEX7 as the second gene involved in Refsum disease. Am. J. Hum. Genet. 2003; 72: 471–477
  • van Heel D. A., Franke L., Hunt K. A., Gwilliam R., Zhernakova A., Inouye M., Wapenaar M. C., Barnardo M. C., Bethel G., Holmes G. K., Feighery C., Jewell D., Kelleher D., Kumar P., Travis S., Walters J. R., Sanders D. S., Howdle P., Swift J., Playford R. J., McLaren W. M., Mearin M. L., Mulder C. J., McManus R., McGinnis R., Cardon L. R., Deloukas P., Wijmenga C. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 2007; 39: 827–829
  • Vesell E. S. Polymorphism of human lactate dehydrogenase isozymes. Science 1965; 148: 1103–1105
  • Vesell E. S. New directions in pharmacogenetics: Introduction. Fed Proc 1984; 43: 2319–2325
  • Vesell E. S., Page J. G. Genetic control of drug levels in man: Antipyrine. Science 1968; 161: 72–73
  • Vesell E. S., Penno M. B. A new polymorphism of hepatic drug oxidation in humans: Family studies of antipyrine metabolites. Fed Proc 1984; 43: 2342–2347
  • Vogel F. Moderne probleme der humangenetik. Ergeb Inn Med Kinderheilkd 1959; 12: 52–125
  • Von Wartburg J. P., Bethune J. L., Vallee B. L. Human liver-alcohol dehydrogenase. Kinetic and physicochemical properties. Biochemistry 1964; 3: 1775–1782
  • Walsh T., Casadei S., Coats K. H., Swisher E., Stray S. M., Higgins J., Roach K. C., Mandell J., Lee M. K., Ciernikova S., Foretova L., Soucek P., King M. C. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006; 295: 1379–1388
  • Wang Y., Krishnan H. R., Ghezzi A., Yin J. C. P., Atkinson N. S. Drug-induced epigenetic changes produce drug tolerance. PLoS Biol 2007; 5: e265
  • Weber W. W. Acetylation pharmacogenetics: experimental models for human toxicity. Fed. Proc. 1984; 43: 2332–2337
  • Weinshilboum R. M. Human pharmacogenetics of methyl conjugation. Fed. Proc. 1984a; 43: 2303–2307
  • Weinshilboum R. M. Human pharmacogenetics: Introduction. Fed Proc 1984b; 43: 2295–2297
  • Weinshilboum R. M., Sladek S. L. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am. J. Hum. Genet. 1980; 32: 651–662
  • Weinstock G. M. ENCODE: More genomic empowerment. Genome Res. 2007; 17: 667–668
  • West M., Ginsburg G. S., Huang A. T., Nevins J. R. Embracing the complexity of genomic data for personalized medicine. Genome Res. 2006; 16: 559–566
  • Wigle E. D. Cardiovascular drugs in muscular subaortic stenosis. Fed Proc 1965; 24: 1279–1286
  • Wilkie M. J., Smith D., Reid I. C., Day R. K., Matthews K., Wolf C. R., Blackwood D., Smith G. A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression. Pharmacogenet. Genomics 2007; 17: 207–215
  • Winkelmann J., Schormair B., Lichtner P., Ripke S., Xiong L., Jalilzadeh S., Fulda S., Putz B., Eckstein G., Hauk S., Trenkwalder C., Zimprich A., Stiasny-Kolster K., Oertel W., Bachmann C. G., Paulus W., Peglau I., Eisensehr I., Montplaisir J., Turecki G., Rouleau G., Gieger C., Illig T., Wichmann H. E., Holsboer F., Muller-Myhsok B., Meitinger T. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 2007; 39: 1000–1006
  • Wong K. K., deLeeuw R. J., Dosanjh N. S., Kimm L. R., Cheng Z., Horsman D. E., MacAulay C., Ng R. T., Brown C. J., Eichler E. E., Lam W. L. A comprehensive analysis of common copy-number variations in the human genome. Am. J. Hum. Genet. 2007; 80: 91–104
  • Woo S. L., Lidsky A. S., Guttler F., Chandra T., Robson K. J. Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 1983; 306: 151–155
  • Yeager M., Orr N., Hayes R. B., Jacobs K. B., Kraft P., Wacholder S., Minichiello M. J., Fearnhead P., Yu K., Chatterjee N., Wang Z., Welch R., Staats B. J., Calle E. E., Feigelson H. S., Thun M. J., Rodriguez C., Albanes D., Virtamo J., Weinstein S., Schumacher F. R., Giovannucci E., Willett W. C., Cancel-Tassin G., Cussenot O., Valeri A., Andriole G. L., Gelmann E. P., Tucker M., Gerhard D. S., Fraumeni J. F., Jr., Hoover R., Hunter D. J., Chanock S. J., Thomas G. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 2007; 39: 645–649
  • Zanke B. W., Greenwood C. M., Rangrej J., Kustra R., Tenesa A., Farrington S. M., Prendergast J., Olschwang S., Chiang T., Crowdy E., Ferretti V., Laflamme P., Sundararajan S., Roumy S., Olivier J. F., Robidoux F., Sladek R., Montpetit A., Campbell P., Bezieau S., O'shea A. M., Zogopoulos G., Cotterchio M., Newcomb P., McLaughlin J., Younghusband B., Green R., Green J., Porteous M. E., Campbell H., Blanche H., Sahbatou M., Tubacher E., Bonaiti-Pellie C., Buecher B., Riboli E., Kury S., Chanock S. J., Potter J., Thomas G., Gallinger S., Hudson T. J., Dunlop M. G. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 2007; 39: 989–994
  • Zhang G., Nebert D. W., Chakraborty R., Jin L. Statistical power of association using the extreme discordant phenotype design. Pharmacogenet. Genomics 2006; 16: 401–413
  • Zhang Y., Liu J. S. Bayesian inference of epistatic interactions in case-control studies. Nat. Genet. 2007; 38: 1167–1173

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.